Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Efavirenz

Efavirenz
In stock
200mg · 600mg
from A$194.45
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$283.22A$236.02
A$7.87 per tablet

In brief

  • In our pharmacy, you can buy efavirenz without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Efavirenz is used to treat and prevent HIV‑1 infection as part of combination antiretroviral therapy; it is a non‑nucleoside reverse transcriptase inhibitor (NNRTI) that blocks HIV reverse transcriptase and prevents viral replication.
  • The usual adult dose is 600 mg orally once daily (taken with or after food); post‑exposure prophylaxis regimens may include 600 mg daily as part of a combination for 28 days; paediatric dosing is weight‑based.
  • Administered orally as tablets (600 mg, 200 mg), capsules (50 mg paediatric, 200 mg) or fixed‑dose combination tablets (eg, Atripla: efavirenz + emtricitabine + tenofovir).
  • Plasma concentrations peak in about 3–5 hours; antiviral effects are usually measurable within 1–2 weeks of starting therapy.
  • Efavirenz has a long half‑life (around 40–55 hours), allowing once‑daily dosing; sustained viral suppression requires ongoing daily treatment.
  • Avoid or limit alcohol while taking efavirenz, as alcohol can worsen central nervous system side effects (eg, dizziness, sleep disturbance) and may increase the risk of liver injury.
  • The most common side effects are central nervous system symptoms such as dizziness, vivid dreams and insomnia; other frequent effects include nausea, rash, fatigue and elevated liver enzymes.
  • Would you like to try efavirenz without a prescription?

Critical Warnings & Patient Protection (Australia)

Basic Efavirenz Information

  • INN (International Nonproprietary Name): Efavirenz.
  • Brand Names Available In Australia: Stocrin; fixed‑dose combination Atripla (efavirenz + emtricitabine + tenofovir) supplied by MSD Australia and Gilead.
  • ATC Code: J05AG03.
  • Forms & Dosages: Tablet 600 mg and 200 mg; capsule 50 mg (paediatric) and 200 mg; combination tablet Atripla (600 mg EFV + 200 mg emtricitabine + 300 mg tenofovir).
  • Manufacturers In Australia: MSD Australia for Stocrin and Gilead for Atripla; multiple generics worldwide (Teva, Mylan, Sandoz, Zentiva) may appear in the market.
  • Registration Status In Australia: Registered and marketed in Australia; clinicians should check the TGA ART index and current product particulars for up‑to‑date information.
  • OTC / Rx Classification: Prescription only (Rx).

High‑Risk Groups

Who should worry before starting efavirenz is a common question for patients and clinicians.

Women Of Child‑Bearing Potential Should Avoid Efavirenz Unless Using Effective Contraception Because Of Teratogenicity Risk; Efavirenz Is Australia Pregnancy Category D.

Patients With A History Of Psychiatric Illness Such As Major Depression Or Psychosis Require Specialist Review Before Prescribing.

People With Seizure Disorders Or A Strong Seizure History Need Specialist Input Because Efavirenz Can Lower Seizure Threshold.

Significant Hepatic Impairment Is A Contraindication; Severe Hepatic Impairment Is An Absolute Contraindication.

Elderly Patients Require Close Monitoring As Pharmacokinetics Are Not Fully Evaluated In This Group.

Use This Baseline Checklist Before Prescribing Or Dispensing Efavirenz.

  • Baseline Mental‑Health Screen (document mood, history of depression or psychosis).
  • Liver Function Tests (ALT, AST, bilirubin) Prior To Start.
  • Pregnancy Test For Women Of Child‑Bearing Potential And Contraception Counselling.
  • Seizure History Review And Neurology Input If Required.
  • Medication Reconciliation For Drug Interactions Including OTC And Herbal Products.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Patients commonly ask whether efavirenz affects driving and work safety.

Efavirenz Frequently Causes Central Nervous System Effects Including Dizziness, Impaired Concentration, Vivid Dreams And Somnolence.

Under Australian Road And Workplace Safety Laws, Patients Must Not Drive Or Operate Heavy Machinery If Experiencing These Effects.

Clinicians And Pharmacists Should Counsel Patients About These Risks And Document The Advice In The Clinical Record.

Recommend A 24–72 Hour Period Of Caution After Treatment Initiation Or Dose Change While Tolerance Is Assessed.

If Symptoms Persist Beyond That Period, Patients Should Seek Medical Review Before Returning To Safety‑Sensitive Tasks.

Patient Handout — Signs That Require Avoidance Of Driving And When To Notify Employer Or Transport Authority.

  • Stop Driving Or Operating Machinery If You Feel Drowsy, Dizzy, Confused Or Have Impaired Concentration.
  • Do Not Drive During The First 1–3 Days After Starting Efavirenz Or After Any Dose Adjustment Unless You Feel Completely Alert.
  • Tell Your Employer If You Work In A Safety‑Critical Role And You Develop Drowsiness, Slowness Or Confusion.
  • Contact Your Prescriber Or Local Clinic If Symptoms Are Severe, WORSEN, Or Last More Than A Few Days.
  • Check State Road Authority Rules If You Hold A Commercial Licence; Some Roles Require Medical Clearance.

Q&A — “Can I Drive After Taking It In Australia?”

Short Answer: Not If You Feel Drowsy, Dizzy, Confused Or Have Impaired Concentration.

Efavirenz Frequently Causes Central Nervous System Side Effects That Can Reduce Fitness To Drive.

If Symptoms Occur, Stop Driving, Inform Your Prescriber And Follow State Road Rules And Workplace Safety Guidance.

Usage Basics

INN, Brand Names Available In Australia

What names will you see on a prescription or at the pharmacy is important for patients ordering locally.

Brand Formulation Supplier Typical Dose
Stocrin Efavirenz 600 mg tablet MSD Australia 600 mg once daily
Atripla Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir 300 mg tablet Gilead One tablet once daily
Generic Efavirenz Tablets 200 mg, 600 mg; Capsules 50 mg (paediatric) Various (Teva, Mylan, Sandoz) 600 mg once daily or weight‑based paediatric dosing

Legal Classification (TGA‑Approved, PBS Considerations)

Is efavirenz subsidised and how to check is a frequent workflow question for prescribers and patients.

Efavirenz Is Prescription‑Only And Registered In Australia; Clinicians Should Check The TGA ART Register For Current Product Particulars And Approved Indications.

PBS Subsidy Status Can Change; Verify Current PBS Listings And Any Special Authority Requirements Before Prescribing For Subsidised Supply.

Note That Different Brands Or Originator Versus Generic Atripla May Have Different Subsidy Arrangements.

Action Steps For Clinicians And Pharmacists.

  • Check The TGA ART Index And Product Information For The Specific Brand Being Prescribed.
  • Check The PBS Schedule For The Current Listing, Item Code And Any Special Authority Criteria.
  • Confirm Brand Availability At Local Pharmacy Chains Before Patient Pickup.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Patients often want to know exactly how to take efavirenz and what to avoid.

Standard Adult Dosing Is 600 Mg Orally Once Daily Taken With Or After Food To Improve Absorption.

Efavirenz Is Always Used As Part Of Combination Antiretroviral Therapy And Never As Monotherapy.

It Is Commonly Prescribed With Two Nucleoside Reverse Transcriptase Inhibitors Or As The Fixed Dose Combination Atripla.

Key Practical Instructions.

  • Take At The Same Time Every Day To Support Adherence.
  • Swallow Tablets Whole; Do Not Crush Fixed‑Dose Combination Tablets.
  • Consider Night‑Time Dosing If CNS Effects Such As Vivid Dreams Or Insomnia Are Problematic.

Adjustments For Comorbidities

Dose changes are uncommon but special populations need tailored advice.

Avoid Efavirenz In Moderate To Severe Hepatic Impairment; Use Caution And Monitor Labs In Mild Hepatic Dysfunction.

No Routine Renal Adjustment Is Required For Mild‑Moderate Renal Impairment, But Use Caution In Severe Renal Failure Due To Limited Data.

Paediatric Dosing Is Weight‑Based; For Example, Children At Or Above 35 Kg May Receive 600 Mg Once Daily.

Weight Bands And Dose Forms
≥35 Kg: 600 Mg Once Daily, Usually Via 600 Mg Tablet.
Lower Weight Bands: Use 200 Mg Or 300 Mg Tablets Or 50 Mg Capsules For Children As Per Paediatric Guidance.

Q&A — “What If I Miss A Dose?”

If You Miss A Single Efavirenz Dose, Take It As Soon As You Remember Unless It Is Near The Next Scheduled Dose.

Do Not Double Up To Make Up A Missed Dose.

For PEP Or Complex Regimens, Contact Your Prescribing Clinic Or Pharmacist For Tailored Advice.

Interaction Chart (Drugs, Food, Alcohol)

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

How you take efavirenz with food and substances can affect levels and tolerability.

Efavirenz Bioavailability Improves With Food, And Taking With A Meal Can Increase Plasma Levels.

For Consistent Exposure, Advise Patients To Take Efavirenz Consistently With Or Without Food Rather Than Varying Each Day.

Alcohol Can Worsen Central Nervous System Side Effects Such As Drowsiness And Dizziness; Counsel Patients To Minimise Alcohol During Initiation.

Caffeine From Coffee Or Energy Drinks May Aggravate Insomnia Or Anxiety In Susceptible Patients.

  • Advice On Food Timing: Take Efavirenz With Or After Food If That Improves Tolerance, But Be Consistent.
  • Alcohol Caution: Avoid Excess Alcohol When Starting Efavirenz Until Tolerance Is Established.
  • Caffeine Moderation: Reduce Late Afternoon Or Evening Caffeine If Experiencing Insomnia Or Vivid Dreams.

Common Drug Conflicts

Efavirenz Is A Known Inducer Of Cytochrome P450 Enzymes, Which Leads To Clinically Significant Interactions.

Certain Co‑Medications Are ContraindICATED Or Require Close Review And Monitoring.

Interacting Drug Effect Recommended Action
Voriconazole Reduced Voriconazole Levels; Risk Of Loss Of Antifungal Efficacy Avoid Co‑Administration
Elbasvir/Grazoprevir Clinically Significant Interaction Avoid Co‑Administration
St John’s Wort Induces Metabolism, Reduces Efavirenz Levels Avoid Herbal Supplement
Certain Benzodiazepines Altered Levels; Increased Sedation Or Reduced Efficacy Monitor Or Choose Alternatives
Ergot Derivatives Risk Of Serious Adverse Events Avoid Co‑Administration

Perform Medication Reconciliation At Every Visit And Include Over‑The‑Counter, Herbal And Recreational Substances.

User Reports & Trends (Australian Patient Feedback)

Patients report practical experiences that help clinicians set expectations during counselling.

Common Themes From Australian Patient Feedback Include Vivid Dreams, Initial Dizziness, And Improved Tolerance After 2–4 Weeks.

Cost Sensitivity And Preference For PBS‑Subsidised Alternatives Appear Frequently In Consumer Discussions.

Remember That These Are Anecdotal Reports And Will Vary Between Individuals.

Encourage Patients To Report Adverse Events Via The TGA Adverse Event Reporting System.

  • Frequent Reports: Vivid Dreams, Insomnia, Initial Dizziness.
  • Typical Time Course: Many Patients Notice CNS Symptoms In The First Days To Weeks, With Improvement By 2–4 Weeks.
  • Cost And Access: Patients Often Prefer PBS‑Subsidised Products Or Fixed‑Dose Tablets Like Atripla For Simplicity.

Checklist: Seek Medical Help For Persistent Mood Change, New Suicidal Ideation, Severe Rash, Or Signs Of Liver Injury.

Access & Purchase Options (Australia)

National Chains And Community Pharmacies

Where to get efavirenz locally is key for adherence and timely supply.

Stocrin And Atripla Are Available Through Major Retail Pharmacies Such As Chemist Warehouse, Priceline, TerryWhite Chemmart And Independent Community Pharmacies, Though Availability May Vary By Stock And Generics.

Advise Patients To Call Ahead To Confirm Brand And PBS Status.

  • Required Prescription From An Authorised Prescriber.
  • Bring Photo ID For Some Pharmacy Services Or Home Delivery.
  • Concession Card For PBS Pricing Where Applicable.
  • Special Authority Or Authority Codes May Be Required For Subsidy Depending On Item Listing.

In Our Online Pharmacy, Efavirenz Is Available Without A Prescription, With Discreet Delivery To Australia In 9–21 Days.

Online Pharmacies And Telehealth E‑Prescriptions

Telehealth Has Changed How Patients Access ART, Including Efavirenz, Especially For Rural Patients.

E‑Prescriptions Via Telehealth Are Accepted When Clinically Appropriate, And Online Pharmacies Can Dispense To Metropolitan And Rural Addresses.

Verify Prescription Authenticity And PBS Rebate Rules When Ordering Online.

  • Advice: Request A Pharmacist Counselling Session By Phone Or Video For First Supply.
  • Safe Online Purchasing Tips: Only Buy From TGA‑Compliant, Australian‑Registered Pharmacies.
  • Red Flags: Websites That Do Not Require A Prescription Or Offer Overseas Suppliers Without TGA Approval.

Mechanism & Pharmacology

Simplified Explanation

Patients often want a simple sentence to explain how efavirenz works.

Efavirenz Is A Non‑Nucleoside Reverse Transcriptase Inhibitor That Binds Directly To HIV‑1 Reverse Transcriptase, Causing A Conformational Change And Blocking Viral Replication.

It Has A Long Half‑Life Which Allows Once‑Daily Dosing As Part Of Combination Antiretroviral Therapy To Suppress Viral Load.

Mechanism Steps
Efavirenz Binds To Reverse Transcriptase.
Binding Alters Enzyme Shape And Prevents Viral DNA Synthesis.
This Results In Reduced Viral Replication When Combined With Other Antiretroviral Agents.

Clinical Terms (For Clinicians)

For prescribing clinicians the pharmacology summary below is helpful for monitoring and interactions.

Pharmacologically, Efavirenz Is ATC J05AG03, WHO DDD 0.6 G/Day, And A Strong CYP3A4 Inducer With Autoinduction Potential.

Monitor For Central Nervous System Adverse Effects, Hepatotoxicity, And Lipid Changes.

  • PK Highlights: Long Half‑Life, Once‑Daily Dosing, Food Increases Bioavailability.
  • Monitoring Points: Baseline And Follow‑Up LFTs, Mental‑Health Screening, Lipid Profile As Indicated.
  • Resistance Profile: NNRTI‑Class Resistance Can Develop If Used As Monotherapy; Always Use In Combination ART.

Indications & Off‑Label Uses

TGA‑Approved Indications

Understanding approved uses helps align prescribing with regulation and PBS listings.

Indication Typical Regimen Duration
HIV‑1 Infection Efavirenz 600 Mg Once Daily As Part Of Combination ART With Two NRTIs Ongoing Lifelong Therapy
Post‑Exposure Prophylaxis (PEP) Efavirenz 600 Mg Daily In Combination Regimens Usually 28 Days

Check TGA Product Information For Exact Registered Indications And Details.

Off‑Label Uses In Australian Practice

Off‑label Use Of Efavirenz Is Uncommon In Australia Given Availability Of Newer Agents.

Historically Efavirenz Was Used In Some Settings For Pregnant Women Or Specific Resistance Profiles But Current Practice Increasingly Favors Dolutegravir For First‑Line Therapy.

Any Off‑Label Prescribing Requires Informed Consent And Documentation.

  • Consider Off‑Label Use Only After Specialist Review.
  • Document Rationale, Risks, And Patient Consent In The Medical Record.
  • Ensure Adequate Monitoring If Off‑Label Use Is Implemented.

Key Clinical Findings (Major Australian & International Studies 2022–2026)

Efavirenz has a long clinical record, and recent literature compares it with newer agents.

Historically Efavirenz Demonstrated Durable Viral Suppression When Used As Part Of Combination Therapy.

Recent Trials And Guideline Updates From 2022 To 2026 Increasingly Compare NNRTI‑Based Regimens With Integrase Inhibitor Regimens Showing Dolutegravir Superiority In Tolerability And Resistance Barrier.

Efavirenz Remains An Effective Option Where Tolerated And In Some Cost‑Sensitive Programs.

  • Study Highlights: Durable Efficacy But Higher Rates Of CNS Adverse Events Versus Integrase Inhibitors.
  • Guideline Trends: Movement Toward Dolutegravir For First‑Line Regimens Due To Better Tolerability.
  • Practical Takeaway: Efavirenz Is Still Usable If Well Tolerated And Where Cost Or Formulation Needs Make It Appropriate.
Outcome Efavirenz Comparator
Efficacy (Viral Suppression) High When Adherent Similar To Many Regimens
CNS Adverse Events Higher Frequency (Vivid Dreams, Dizziness) Lower With Integrase Inhibitors

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Class Dosing PBS Status Main Advantages Main Risks
Dolutegravir Integrase Inhibitor Once Daily 50 Mg Listed (Check PBS) Better Tolerability, High Barrier To Resistance Watch For Weight Gain In Some Patients
Rilpivirine NNRTI Once Daily With Food Listed For Specific Uses Fewer CNS Effects Food‑Dependent; Not For High Viral Loads
Etravirine NNRTI (Second Generation) Twice Daily Limited PBS Listings Useful For Some Resistance Profiles Complex Dosing, GI Side Effects
Nevirapine NNRTI Twice Daily Or Extended Regimen Listed For Some Uses Established History Hepatotoxicity Risk

Pros/Cons Checklist When Considering An Alternative.

  • Dolutegravir: Consider For Most First‑Line Patients Unless Contraindicated.
  • Rilpivirine: Consider If CNS Effects From Efavirenz Are Problematic But Ensure Food Compliance.
  • Etravirine Or Nevirapine: Consider Specialist Input For Resistance Or Specific Clinical Scenarios.

Common Questions (Australian Pharmacy Consultations)

Pharmacists answer several recurring questions when dispensing efavirenz.

  • Do Oral Contraceptives Interact With Efavirenz? Use Reliable Contraception And Counsel That Efavirenz May Reduce Hormonal Contraceptive Levels; Discuss Long‑Acting Options If Concerned.
  • What About Pregnancy Planning? Women Of Child‑Bearing Potential Should Avoid Efavirenz Unless Using Effective Contraception; Discuss Risks And Alternatives Such As Dolutegravir.
  • How Safe Is Switching Regimens? Switching Requires Clinical Review, Resistance Data Where Relevant, And Monitoring Of Viral Load After Switch.
  • When Do Side Effects Appear And Resolve? CNS Effects Usually Start Within Days And Often Improve Over 2–4 Weeks; Seek Urgent Care For Severe Rash Or Mood Changes.
  • How Should Efavirenz Be Stored At Home? Store Below 30°C And Protect From Moisture And Light.
  • What If I Miss A Dose? Take As Soon As Remembered Unless Close To Next Dose; Do Not Double Dose.
  • How To Report Adverse Events? Report To The TGA Adverse Event System And Inform The Prescriber.

Pharmacist Counselling Checklist For Efavirenz Supply.

  • Baseline Tests: LFTs, Viral Load Where Applicable, Mental‑Health Screen.
  • Adherence Support: Pill Boxes, SMS Reminders, Or Pharmacy Dose‑Administration Aids.
  • Mental‑Health Screening And Safety Planning If Depression Or Suicidal Ideation Is Present.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Requirement

Pharmacy/Source Typical Price Range PBS Subsidy Prescription Required
Chemist Warehouse Varies By Brand/Stock Check Current PBS Listing Yes
Priceline Varies By Brand/Stock Check Current PBS Listing Yes
TerryWhite Chemmart Varies By Brand/Stock Check Current PBS Listing Yes
Reputable Online Pharmacies (Australian) Varies; May Include Delivery Fee Check PBS Rules For E‑Prescriptions Yes (Valid Prescription Required)

Access Checklist For Rural Patients.

  • Use Mail Order Or Pharmacy Delivery Services For Ongoing Supply.
  • Schedule Refills Early To Avoid Gaps If Delivery Times Are Longer.
  • Confirm PBS Eligibility And Concession Card Details At Time Of Order.

Registration & Regulation

TGA Approval

Regulatory status affects what products can be legally supplied in Australia.

Efavirenz Products Such As Stocrin And Atripla Are Registered In Australia.

Clinicians And Pharmacists Should Check The TGA ART Index And Product Particulars For Up‑To‑Date Registration And Safety Updates.

Report Suspected Adverse Reactions To The TGA Using The Adverse Event Reporting Processes.

  • How To Check The TGA: Visit The TGA Website And Search The ART Index For Product Information.
  • How To Report: Use The TGA ADR Reporting Portal Or The Adverse Medicine Event Reporting Form.

PBS Subsidy Details

PBS Listings Differ By Formulation And Brand, So Always Confirm The Current Schedule Entry.

Clinicians Should Confirm PBS Item Code And Any Special Authority Requirements Prior To Prescribing For Subsidised Supply.

  • Confirm The PBS Item Code At Time Of Prescription.
  • Ensure The Prescriber Includes Concession Details If Relevant.
  • Advise The Patient About The Co‑Payment And Concession Eligibility.

Storage & Handling (Australian Climate)

Household Storage (Heat/Humidity)

Australian summers can be hot and humid, so storage advice needs to be practical.

Store Efavirenz Below 30°C And Protect From Moisture And Light.

Advise Patients To Keep Tablets In A Cool, Dry Place Such As A Bedroom Cupboard Rather Than A Bathroom Or Car.

If Blister Packs Or Bottles Are Exposed To Excessive Heat Or Moisture, Return Them To The Pharmacy For Advice.

Safe Disposal: Return Unwanted Medicines To A Pharmacy Take‑Back Service.

  • Ideal Storage Spots: Linen Cupboard (Away From Steam), Bedroom Cupboard, Or Kitchen Cabinet Away From Stove Heat.
  • If Exposed To Extreme Heat: Do Not Use; Consult The Dispensing Pharmacist.
  • Safe Disposal: Use Pharmacy Return Programs Rather Than Household Rubbish.

Cold‑Chain And Pharmacy Handling

No Special Cold‑Chain Is Required For Efavirenz Products.

Pharmacies Should Follow TGA Good Distribution Practice For Storage And Transport.

For Remote Deliveries Use Tracked Courier Services; Temperature‑Controlled Packaging Is Only Needed If Recommended By The Manufacturer.

  • Pharmacy SOPs: Stock Rotation, Temperature Logs, And Secure Storage.
  • Deliveries: Use Reliable Couriers With Tracking For Rural And Remote Areas.

Guidelines For Proper Use (Pharmacist Counselling & Patient Advice)

Australian Pharmacist Counselling Style

Patients need clear, concise counselling the first time they collect efavirenz.

Counselling Should Cover Purpose, Dosing, Common Side Effects, Interactions, Driving And Work Safety, Pregnancy Risks, Adherence Importance, Missed Dose Guidance, And When To Seek Urgent Care.

Emphasise The Importance Of Taking Efavirenz As Part Of Combination Therapy To Prevent Resistance.

Provide Written Information And A Short Verbal Review On First Supply.

  • Mandatory Counselling Points: 600 Mg Once Daily With/After Food, CNS Side Effects, Pregnancy Risks, Interactions With St John’s Wort.
  • Provide A Patient Information Leaflet And Document Counselling In The Pharmacy Record.

Patient Advice Drawn From PBS And National Health Authorities

Follow National Guidance On Monitoring And Follow‑Up When Starting Or Changing Antiretroviral Therapy.

Advise Patients To Bring All Medicines Including Supplements To Appointments And Attend Regular Monitoring For Viral Load, Liver Function Tests And Lipids.

Report Mood Changes Or Severe Rash Immediately And Consider Referral To Local HIV Support Services.

  • Follow‑Up Schedule: Baseline, 2–4 Weeks After Start, 3 Months, Then Per Specialist Guidelines.
  • Encourage Vaccination Review And Ongoing Adherence Support.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 14-21 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Sunshine Coast Queensland 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days

Related products